Purple Biotech (PPBT) Assets (2014 - 2026)
Purple Biotech's Assets came in at $14.17 million for Q2 2026, down 58.8% from $34.38 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Purple Biotech's Assets was $17.57 million, down 52.6% from FY2024.
- Assets has declined in each of the last five years, with a five-year compound annual growth rate of -26.8% (FY2020 to FY2025).
- Going back by year, Assets was $37.04 million in FY2024 (-16.4%), $44.3 million in FY2023 (-18.9%), $54.62 million in FY2022 (-22.2%) and $70.2 million in FY2021 (-16.2%).
- The Q2 2026 figure represents the lowest quarterly Assets since Q2 2016.
- Year-over-year, Assets has declined for three consecutive quarters, with an average decline of 26.7% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2025 (growth of 11.3%), and the weakest in Q1 2026 (a decline of 59.5%).
- Business Quant data shows PPBT's Assets at $14.42 million (Q1 2026), $17.57 million (Q4 2025) and $39.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | 14.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.17 Mn |
| Mar 31, 2026 | 14.42 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 39.06 Mn |
| Jun 30, 2025 | 34.38 Mn |
| Mar 31, 2025 | 35.59 Mn |
| Dec 31, 2024 | 37.04 Mn |
| Sep 30, 2024 | 35.11 Mn |
| Jun 30, 2024 | 36.07 Mn |
| Mar 31, 2024 | 39.86 Mn |
| Dec 31, 2023 | 44.30 Mn |
| Sep 30, 2023 | 45.27 Mn |
| Jun 30, 2023 | 48.00 Mn |
| Mar 31, 2023 | 53.08 Mn |
| Dec 31, 2022 | 54.62 Mn |
| Sep 30, 2022 | 58.54 Mn |
| Jun 30, 2022 | 61.74 Mn |
| Mar 31, 2022 | 66.29 Mn |
| Dec 31, 2021 | 70.20 Mn |
| Sep 30, 2021 | 73.63 Mn |
API Access
Purple Biotech Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();